Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of purchasers of DocGo Inc. (NASDAQ: DCGO) ("DocGo") securities between November 15, 2021 and January 9, 2024.
On January 10, 2024, before the market opened, market analyst Fuzzy Panda released a report on DocGo titled, “DocGo – Allegations of Fraudulent Billing Practices & Forging of Documents.” Specifically, Fuzzy Panda found that “through former employee interviews and never before seen lawsuits we discovered serious allegations that DocGo (DCGO) has allegedly been committing Medicare fraud and having employees forge signatures on medical documents.”
Following this news, the price of DocGo stock fell over 30% during intraday trading, to close at $2.99 per share on January 10, 2024.
If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.